The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer.

PubWeight™: 1.30‹?› | Rank: Top 10%

🔗 View Article (PMC 2880994)

Published in BMC Cancer on May 20, 2010

Authors

Fuqiang Dai1, Lunxu Liu, Guowei Che, Nanbin Yu, Qiang Pu, Shangfu Zhang, Junliang Ma, Lin Ma, Zongbing You

Author Affiliations

1: Department of Thoracic and Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.

Articles citing this

The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS One (2012) 2.05

Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis. Clin Cancer Res (2013) 1.67

The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages. Oncologist (2012) 1.41

Anti-tumour strategies aiming to target tumour-associated macrophages. Immunology (2013) 1.40

Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer. Am J Transl Res (2012) 1.37

Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer. J Thorac Oncol (2012) 1.10

Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma. Virchows Arch (2011) 1.00

Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic model. Breast Cancer Res (2012) 0.94

Clinical significance of the tumor microenvironment in non-small cell lung cancer. Ann Transl Med (2013) 0.92

Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs. Breast Cancer Res Treat (2014) 0.91

Clinical evaluation of systemic and local immune responses in cancer: time for integration. Cancer Immunol Immunother (2013) 0.89

Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment. BMC Cancer (2012) 0.88

Non-Small-Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy. J Thorac Oncol (2015) 0.87

S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma. Hepat Mon (2012) 0.87

The Microenvironmental Effect in the Progression, Metastasis, and Dormancy of Breast Cancer: A Model System within Bone Marrow. Int J Breast Cancer (2012) 0.86

Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer. Oncotarget (2016) 0.86

Peripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapy. PLoS One (2013) 0.85

Tumor-associated macrophages in stage IIIA pN2 non-small cell lung cancer after neoadjuvant chemotherapy and surgery. Am J Transl Res (2014) 0.83

The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients. Oncotarget (2016) 0.81

Interferon-γ and celecoxib inhibit lung-tumor growth through modulating M2/M1 macrophage ratio in the tumor microenvironment. Drug Des Devel Ther (2014) 0.81

Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis. Oncotarget (2016) 0.81

Influence of human immune cells on cancer: studies at the University of Colorado. Immunol Res (2013) 0.80

Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis. Oncoimmunology (2012) 0.80

Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease. BMC Immunol (2013) 0.80

Anti-tumor immune response in early stage non small cell lung cancer (NSCLC): implications for adjuvant therapy. Transl Lung Cancer Res (2013) 0.80

Cellular and molecular immunology of lung cancer: therapeutic implications. Expert Rev Clin Immunol (2014) 0.79

Parallel Aspects of the Microenvironment in Cancer and Autoimmune Disease. Mediators Inflamm (2016) 0.78

Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta-analysis. Oncotarget (2016) 0.76

The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy. Onco Targets Ther (2017) 0.75

Urinary levels of prostaglandin E2 are positively correlated with intratumoral infiltration of Foxp3(+) regulatory T cells in non-small cell lung cancer. Oncol Lett (2017) 0.75

Heterogeneity of CD8(+) tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategies. Cancer Immunol Immunother (2016) 0.75

Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation. Transl Lung Cancer Res (2017) 0.75

Articles cited by this

Inflammation and cancer: back to Virchow? Lancet (2001) 27.40

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol (2002) 17.85

Revisions in the International System for Staging Lung Cancer. Chest (1997) 15.68

Macrophage polarization comes of age. Immunity (2005) 5.67

The origin and function of tumor-associated macrophages. Immunol Today (1992) 5.12

Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol (2008) 4.30

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med (1996) 3.82

New vistas on macrophage differentiation and activation. Eur J Immunol (2007) 2.99

Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Cancer (2008) 2.32

Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol (2004) 2.26

Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br J Cancer (2006) 2.09

Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res (2003) 1.89

Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol (2005) 1.87

Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur Respir J (2009) 1.80

Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med (2002) 1.61

Significance of the number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol (2006) 1.49

High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer. Br J Cancer (2008) 1.41

The tumor microenvironment in the post-PAGET era. Cancer Lett (2006) 1.39

The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma. Histopathology (2009) 1.28

Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer. BMC Cancer (2009) 1.20

CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Med Oncol (2009) 1.11

The immune system and cancer. Cancer Biother Radiopharm (2009) 1.11

Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth. Immunol Lett (2009) 1.05

Infiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: No association with prognosis identified in 3-year follow-up. Int J Cancer (2003) 1.02

Independent predictive value of the overall number of metastatic N1 and N2 stations in lung cancer. Jpn J Thorac Cardiovasc Surg (2003) 0.90

Characterisation of dendritic cell subsets in lung cancer micro-environments. Eur Respir J (2006) 0.88

Engagement of CD83 on B cells modulates B cell function in vivo. J Immunol (2009) 0.82

Articles by these authors

Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat Neurosci (2007) 3.81

Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging (2002) 3.35

A pilot study of functional magnetic resonance imaging of the brain during manual and electroacupuncture stimulation of acupuncture point (LI-4 Hegu) in normal subjects reveals differential brain activation between methods. J Altern Complement Med (2002) 2.70

Functional investigation of Fas ligand expressions in human non-small cell lung cancer cells and its clinical implications. Ann Thorac Surg (2012) 2.63

A new concept of endoscopic lung cancer resection: Single-direction thoracoscopic lobectomy. Surg Oncol (2009) 2.31

Volume of mammographic density and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 2.18

The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer (2010) 2.03

Hepatocellular carcinoma: stiffness value and ratio to discriminate malignant from benign focal liver lesions. Radiology (2015) 2.03

On the statistical errors of RADAR location sensor networks with built-in Wi-Fi Gaussian linear fingerprints. Sensors (Basel) (2012) 1.97

Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice. Arthritis Rheum (2004) 1.94

Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood (2011) 1.83

RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis. J Bone Miner Res (2004) 1.83

Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood (2014) 1.81

Mlx is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes. J Biol Chem (2004) 1.80

Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review. Arch Pediatr Adolesc Med (2011) 1.76

Experimental demonstration of 4D imaging in two-phase flows based on computed tomography at 5  kHz. Appl Opt (2014) 1.69

Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter. J Biol Chem (2002) 1.60

Simultaneous detection and serotype identification of Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization. J Med Microbiol (2005) 1.59

Cardiopulmonary arrest following cervical epidural injection. Pain Physician (2012) 1.56

Diagnostic value of minimum apparent diffusion coefficient values in prediction of neuroepithelial tumor grading. J Magn Reson Imaging (2010) 1.54

Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology (2006) 1.49

Synthesis and biological evaluation of helicid analogues as novel acetylcholinesterase inhibitors. Eur J Med Chem (2007) 1.48

Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population. Nat Genet (2011) 1.46

Video-assisted thoracic surgery versus open thoracotomy for non-small-cell lung cancer: a propensity score analysis based on a multi-institutional registry. Eur J Cardiothorac Surg (2013) 1.44

Comparison of three-dimensional volume-targeted thin-slab FIESTA magnetic resonance angiography and 64-multidetector computed tomographic angiography for the identification of proximal coronary stenosis. Int J Cardiol (2012) 1.39

Alpha-glucosidase inhibition of natural curcuminoids and curcumin analogs. Eur J Med Chem (2006) 1.32

Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer. Proc Natl Acad Sci U S A (2013) 1.32

Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain. J Neurosci (2010) 1.31

Complete nucleotide sequence and organization of the naphthalene catabolic plasmid pND6-1 from Pseudomonas sp. strain ND6. Gene (2004) 1.28

Applications of loop-mediated isothermal DNA amplification. Appl Biochem Biotechnol (2010) 1.27

Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models. Cancer Res (2012) 1.26

Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol (2010) 1.25

A screen for downstream effectors of Neurogenin2 in the embryonic neocortex. Dev Biol (2004) 1.24

Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res (2013) 1.23

Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B. J Biol Chem (2002) 1.21

Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed cases. Indian J Dermatol (2011) 1.21

Asperterpenols A and B, new sesterterpenoids isolated from a mangrove endophytic fungus Aspergillus sp. 085242. Org Lett (2013) 1.19

Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics (2009) 1.17

1-(1-Arylethylidene)thiosemicarbazide derivatives: a new class of tyrosinase inhibitors. Bioorg Med Chem (2008) 1.17

Synthesis and biological evaluation of novel 4-hydroxybenzaldehyde derivatives as tyrosinase inhibitors. Eur J Med Chem (2009) 1.17

Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer. Cancer Res (2004) 1.15

MicroRNA-143 inhibits migration and invasion of human non-small-cell lung cancer and its relative mechanism. Int J Biol Sci (2013) 1.13

Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain. Mol Pain (2008) 1.13

Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients. J Exp Clin Cancer Res (2010) 1.12

A novel method for troubleshooting vascular injury during anatomic thoracoscopic pulmonary resection without conversion to thoracotomy. Surg Endosc (2012) 1.11

Design, synthesis and biological evaluation of hydroxy- or methoxy-substituted phenylmethylenethiosemicarbazones as tyrosinase inhibitors. Chem Pharm Bull (Tokyo) (2009) 1.10

Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer. J Thorac Oncol (2012) 1.10

Epidemiological and molecular characteristics of clinical isolates of Streptococcus pyogenes collected between 2005 and 2008 from Chinese children. J Med Microbiol (2012) 1.09

Clusters of sudden unexplained death associated with the mushroom, Trogia venenata, in rural Yunnan Province, China. PLoS One (2012) 1.09

In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods. Antimicrob Agents Chemother (2007) 1.09

Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis (2010) 1.08

Value of video-assisted thoracic surgery core needle biopsy in the selection of surgical approaches for indeterminate pulmonary nodules. Ann Thorac Surg (2013) 1.08

Is intracavitary thoracoscopic ultrasonography really needed for every intraparenchymal pulmonary nodule? J Thorac Cardiovasc Surg (2013) 1.08

Is the extent of fat dissection correlated with complete stable remission of myasthenia gravis? Ann Surg (2013) 1.07

Activation of mammalian target of rapamycin pathway confers adverse outcome in nonsmall cell lung carcinoma. Cancer (2011) 1.07

Impaired response inhibition function in abstinent heroin dependents: an fMRI study. Neurosci Lett (2008) 1.06

Dilemma in pulmonary metastasectomy: video-assisted thoracoscopic surgery or thoracotomy? Chest (2013) 1.06

Inflammatory-mediated repression of the rat ileal sodium-dependent bile acid transporter by c-fos nuclear translocation. Gastroenterology (2002) 1.06

Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells. Cancer Res (2003) 1.05

Curcumin analogs as potent aldose reductase inhibitors. Arch Pharm (Weinheim) (2006) 1.05

Roles of Kruppel-associated Box (KRAB)-associated Co-repressor KAP1 Ser-473 Phosphorylation in DNA Damage Response. J Biol Chem (2012) 1.04

A class of potent tyrosinase inhibitors: alkylidenethiosemicarbazide compounds. Eur J Med Chem (2008) 1.04

Grey matter volume changes over the whole brain in amyotrophic lateral sclerosis: A voxel-wise meta-analysis of voxel based morphometry studies. Amyotroph Lateral Scler (2010) 1.03

A functional MRI evaluation of frontal dysfunction in patients with severe obstructive sleep apnea. Sleep Med (2011) 1.02

Expression of interleukin-17RC protein in normal human tissues. Int Arch Med (2008) 1.01

Akt is the downstream target of GRP78 in mediating cisplatin resistance in ER stress-tolerant human lung cancer cells. Lung Cancer (2011) 1.01

Kalman/Map filtering-aided fast normalized cross correlation-based Wi-Fi fingerprinting location sensing. Sensors (Basel) (2013) 1.01

Is chemical incompatibility responsible for chondrocyte death induced by local anesthetics? Am J Sports Med (2010) 1.01

The origin of fluorescence from graphene oxide. Sci Rep (2012) 1.00

Mapping the brain in type II diabetes: Voxel-based morphometry using DARTEL. Eur J Radiol (2011) 1.00

Language barriers, location of care, and delays in follow-up of abnormal mammograms. Med Care (2012) 0.99

Liposomal extended-release bupivacaine for postsurgical analgesia. Patient Prefer Adherence (2013) 0.99

Video-assisted thoracic surgery for pulmonary sequestration compared with posterolateral thoracotomy. J Thorac Cardiovasc Surg (2013) 0.98

A multicenter retrospective analysis of survival outcome following postoperative chemoradiotherapy in non-small-cell lung cancer patients with N2 nodal disease. Int J Radiat Oncol Biol Phys (2009) 0.98

Synthesis and evaluation of quindoline derivatives as G-quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase. J Med Chem (2005) 0.97

Intra- and interscanner reliability and reproducibility of 3D whole-brain pseudo-continuous arterial spin-labeling MR perfusion at 3T. J Magn Reson Imaging (2013) 0.97

Combined MR spectroscopic imaging and diffusion tensor MRI visualizes corticospinal tract degeneration in amyotrophic lateral sclerosis. J Neurol (2004) 0.96

Corticospinal tract degeneration in amyotrophic lateral sclerosis: a diffusion tensor imaging and fibre tractography study. Ann Acad Med Singapore (2008) 0.96

Minimization of MR contrast weightings for the comprehensive evaluation of carotid atherosclerotic disease. Invest Radiol (2010) 0.95

A reinforcement sensor embedded vertical handoff controller for vehicular heterogeneous wireless networks. Sensors (Basel) (2013) 0.95

Pharmacological switch in Abeta-fiber stimulation-induced spinal transmission in mice with partial sciatic nerve injury. Mol Pain (2008) 0.95

Dynamic neural responses to cue-reactivity paradigms in heroin-dependent users: an fMRI study. Hum Brain Mapp (2009) 0.94

Intracranial hemangiopericytoma: MR imaging findings and diagnostic usefulness of minimum ADC values. J Magn Reson Imaging (2013) 0.94